Dr. Sunil Rohatgi, MD

Dr. Rohatgi practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Rohatgi's NPI, 1912351727, was assigned on April 18, 2016. Dr. Rohatgi graduated from University Of Florida College Of Medicine in 2016. Dr. Rohatgi holds Florida license ME155567.

Dr. Rohatgi's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Rohatgi's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Rohatgi is also affiliated with HCA Florida Citrus Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Rohatgi to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rohatgi practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Rohatgi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Rohatgi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rohatgi's licenses on file in 3 states: Florida, Texas and New York.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Rohatgi treats.

CMS data shows 53,065 Medicare services from Dr. Rohatgi across 39 procedure codes in 2024, for 781 Medicare patients. Medicare paid $785,987 for them.

CMS counts 781 Medicare patients who saw Dr. Rohatgi in 2024. The largest group is 75 to 84, with 337 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rohatgi's median patient age at 73, with 59% women.

In 2024, Dr. Rohatgi wrote 2,663 Medicare Part D claims for 440 patients. 79% of them were for generic drugs. CMS names the drug for 2,202 of them, across 58 drugs with 11 or more claims each, at $3,563,561 in total drug cost. In 2023, CMS named 996 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Rohatgi for performance year 2024, reported through an alternative payment model (APM). Dr. Rohatgi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Rohatgi in 2025.

CMS Open Payments shows 236 general payments to Dr. Rohatgi from 49 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 93% of the total. Pfizer Inc. paid the most, $763.

Dr. Rohatgi graduated from University Of Florida College Of Medicine in 2016. Dr. Rohatgi is a member of ASCO.

Dr. Rohatgi is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.